[ad_1]
Clinical trials of drugs to address memory loss, daily forgetfulness of events and faces that occur in older adults with early-stage Alzheimer's disease should be conducted in man.
The new medicine is taken daily as a pill. It strengthens the brain cells in its original activity, keeps the brain of the elderly acute and attacks moderate cognitive impairment of patients with Alzheimer's disease.
The drug, according to Daily Mail, is a type of antidepressant and depression, but unlike valium, which has a wide range of harmful side effects, the modified version is able to target specific alterations in memory brain.
Source link
